Total Payments
$8,677
2023 Payments
$248.72
Companies
15
Transactions
45
Payment Breakdown by Category
Other$6,500 (74.9%)
Food & Beverage$1,694 (19.5%)
Travel$482.90 (5.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,500 | 2 | 74.9% |
| Food and Beverage | $1,694 | 40 | 19.5% |
| Travel and Lodging | $482.90 | 3 | 5.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $7,120 | 7 | $0 (2017) |
| AbbVie Inc. | $242.94 | 2 | $0 (2023) |
| Zimmer Biomet Holdings, Inc. | $223.02 | 1 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $190.24 | 7 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $186.65 | 7 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $184.43 | 7 | $0 (2017) |
| Nuvectra Corporation | $114.62 | 1 | $0 (2017) |
| Mallinckrodt LLC | $108.77 | 1 | $0 (2017) |
| Horizon Therapeutics plc | $106.62 | 1 | $0 (2023) |
| Lundbeck LLC | $56.56 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $248.72 | 3 | AbbVie Inc. ($120.35) |
| 2022 | $122.59 | 1 | ABBVIE INC. ($122.59) |
| 2017 | $8,305 | 41 | Alkermes, Inc. ($7,120) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/08/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/01/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $120.35 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $106.62 | General |
| Category: KRYSTEXXA | ||||||
| 09/14/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $122.59 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $89.96 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2017 | Zimmer Biomet Holdings, Inc. | CMF Non (Device) | Travel and Lodging | In-kind items and services | $223.02 | General |
| Category: CMF & Thoracic | ||||||
| 08/08/2017 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $11.50 | General |
| Category: PSYCHIATRY | ||||||
| 07/25/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: PSYCHIATRY | ||||||
| 07/18/2017 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: Neuroscience | ||||||
| 07/17/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: CNS | ||||||
| 06/22/2017 | Janssen Pharmaceuticals, Inc | INVEGA TRINZA (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Neuroscience | ||||||
| 06/21/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $219.46 | General |
| Category: CNS | ||||||
| 06/10/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Travel and Lodging | In-kind items and services | $145.26 | General |
| Category: CNS | ||||||
| 06/06/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: CNS | ||||||
| 06/01/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,400.00 | General |
| Category: CNS | ||||||
| 05/30/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY TABLET (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: PSYCHIATRY | ||||||
| 05/23/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Central Nervous System (CNS) | ||||||
| 05/18/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $157.06 | General |
| Category: CNS | ||||||
| 05/16/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: PSYCHIATRY | ||||||
| 05/16/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: CNS | ||||||
| 05/16/2017 | Janssen Pharmaceuticals, Inc | INVEGA TRINZA (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Neuroscience | ||||||
| 05/09/2017 | Vanda Pharmaceuticals Inc. | Fanapt (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Schizophrenia | ||||||
| 04/25/2017 | Vanda Pharmaceuticals Inc. | Fanapt (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Schizophrenia | ||||||
| 04/18/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: CNS | ||||||
About Dr. Muhammad Arshad, M.D
Dr. Muhammad Arshad, M.D is a Psychiatry healthcare provider based in Gretna, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598876955.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Arshad, M.D has received a total of $8,677 in payments from pharmaceutical and medical device companies, with $248.72 received in 2023. These payments were reported across 45 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($6,500).
Ad
Practice Information
- Specialty Psychiatry
- Location Gretna, LA
- Active Since 08/31/2006
- Last Updated 07/13/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598876955
Products in Payments
- Aristada 441 mg (Drug) $7,120
- VRAYLAR (Drug) $274.88
- CMF Non (Device) $223.02
- INVEGA TRINZA (Drug) $205.28
- LATUDA (Drug) $186.65
- ABILIFY MAINTENA (Drug) $158.94
- Algovita (Device) $114.62
- ACTHAR (Biological) $108.77
- KRYSTEXXA (Biological) $106.62
- REXULTI (Drug) $64.33
- INVEGA SUSTENNA (Drug) $29.15
- ABILIFY TABLET (Drug) $23.53
- Fanapt (Drug) $22.22
- NUPLAZID (Drug) $21.75
- Trintellix (Drug) $17.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.